Clinical Trial Update: Post-Market Clinical Investigation of NanoFUSE® Bioactive Matrix [Phase 4]

View source ↗

Summary

Phase 4 post-market clinical investigation update for NanoFUSE Bioactive Matrix (bone-related conditions).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Degeneration
• Bone Degeneration Disease
• Bone Disorders

Drugs mentioned

• NanoFUSE Bioactive Matrix

Snippet

Sponsor: NanoFUSE Biologics, LLC | Conditions: Bone; Degeneration | Phase 4 | Status: UNKNOWN